v3.26.1
Share-based awards - Share options (Details)
$ / shares in Units, ¥ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2026
CNY (¥)
shares
Mar. 31, 2026
USD ($)
$ / shares
shares
Mar. 31, 2026
CNY (¥)
$ / shares
shares
Mar. 31, 2025
CNY (¥)
shares
Mar. 31, 2025
$ / shares
Mar. 31, 2025
$ / shares
Mar. 31, 2024
CNY (¥)
Mar. 31, 2024
$ / shares
Mar. 31, 2024
$ / shares
Mar. 31, 2026
$ / shares
Mar. 31, 2026
$ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]                      
Share-based compensation expense ¥ 11,180 $ 1,621   ¥ 13,970     ¥ 18,546        
2014 Plan                      
Number of share options                      
Outstanding at beginning of year | shares 6,635,667 6,635,667                  
Exercised | shares (2,007,667) (2,007,667)                  
Canceled/forfeited | shares (1,000,000) (1,000,000)                  
Outstanding at end of year | shares 3,628,000 3,628,000   6,635,667              
Vested and exercisable | shares 2,173,000   2,173,000                
Vested and expected to vest | shares 3,628,000   3,628,000                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]                      
Outstanding at beginning of year   $ 88.89                  
Exercised   72.78                  
Canceled/forfeited   182.48                  
Outstanding at end of year   $ 72     $ 88.89            
Vested and exercisable                   $ 71.86  
Vested and expected to vest                   $ 72  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]                      
Weighted average remaining contractual life, outstanding 5 years 2 months 12 days   5 years 2 months 12 days 4 years 6 months 4 years 6 months 4 years 6 months          
Weighted average remaining contractual life, vested and exercisable 3 years 10 months 24 days 3 years 10 months 24 days                  
Weighted average remaining contractual life, vested and expected to vest 5 years 2 months 12 days 5 years 2 months 12 days                  
Additional disclosure                      
Weighted average grant date fair value of share options   $ 0     $ 35.93     $ 40.3      
2024 Plan                      
Number of share options                      
Outstanding at beginning of year | shares 2,933,332 2,933,332                  
Granted | shares 25,439,998 25,439,998                  
Outstanding at end of year | shares 28,373,330 28,373,330   2,933,332              
Vested and exercisable | shares 0   0                
Vested and expected to vest | shares 28,068,375   28,068,375                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]                      
Outstanding at beginning of year     $ 68                
Granted     130.92                
Outstanding at end of year     $ 124.41     $ 68          
Vested and exercisable                     $ 0
Vested and expected to vest                     $ 125.03
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]                      
Weighted average remaining contractual life, outstanding 8 years 10 months 24 days   8 years 10 months 24 days 5 years 10 months 24 days 5 years 10 months 24 days 5 years 10 months 24 days          
Weighted average remaining contractual life, granted 9 years 4 months 24 days 9 years 4 months 24 days                  
Weighted average remaining contractual life, vested and expected to vest 9 years 9 years                  
Additional disclosure                      
Weighted average grant date fair value of share options     $ 86.36     $ 87.27     $ 0    
Share Based Awards Relating To Ant Financial Services                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]                      
Share-based compensation expense | ¥ ¥ (16)     ¥ 4     (6,691)        
Options                      
Additional disclosure                      
Aggregate intrinsic value of all outstanding options | ¥ 1,561   $ 1,561                
Aggregate intrinsic value of options that were vested and exercisable | ¥ 805   805                
Aggregate intrinsic value of options that were vested and expected to vest | ¥ 1,547   1,547                
Total grant date fair value of options vested | ¥ 305     408     238        
Aggregate intrinsic value of share options exercised | ¥ 681     128     382        
Cash received from option exercise under the share option plans | ¥ ¥ 1,042     ¥ 10     ¥ 843        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]                      
Risk-free interest rate             4.50%        
Risk-free interest rate, minimum 2.16% 2.16%   3.36%              
Risk-free interest rate, maximum 2.71% 2.71%   4.49%              
Expected dividend yield 0.00% 0.00%   0.00%     0.00%        
Expected life (years)             6 years 6 months        
Expected volatility             44.80%        
Expected volatility , minimum 49.18% 49.18%   48.51%              
Expected volatility , maximum 51.78% 51.78%   49.44%              
Unamortized compensation costs | ¥ ¥ 1,920   $ 1,920                
Weighted average period over which unamortized compensation costs expected be recognized 3 years 1 month 6 days   3 years 1 month 6 days                
Share-based compensation expense | ¥ ¥ 578     ¥ 349     ¥ 240        
Options | Minimum                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]                      
Expected life (years) 4 years 5 months 12 days 4 years 5 months 12 days   4 years 5 months 12 days              
Options | Maximum                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]                      
Expected life (years) 7 years 6 months 7 years 6 months   4 years 9 months              
Options | 2014 Plan | Maximum                      
Additional disclosure                      
Expiry period 12 years 12 years                  
Options | 2024 Plan | Maximum                      
Additional disclosure                      
Expiry period 10 years 10 years